BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32724091)

  • 1. BDNF belongs to the nurse-like cell secretome and supports survival of B chronic lymphocytic leukemia cells.
    Talbot H; Saada S; Barthout E; Gallet PF; Gachard N; Abraham J; Jaccard A; Troutaud D; Lalloué F; Naves T; Fauchais AL; Jauberteau MO
    Sci Rep; 2020 Jul; 10(1):12572. PubMed ID: 32724091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.
    Abbaci A; Talbot H; Saada S; Gachard N; Abraham J; Jaccard A; Bordessoule D; Fauchais AL; Naves T; Jauberteau MO
    Oncogene; 2018 Feb; 37(6):756-767. PubMed ID: 29059151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.
    Filip AA; Ciseł B; Wąsik-Szczepanek E
    Clin Exp Med; 2015 Feb; 15(1):73-83. PubMed ID: 24337970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia.
    Paiva C; Rowland TA; Sreekantham B; Godbersen C; Best SR; Kaur P; Loriaux MM; Spurgeon SEF; Danilova OV; Danilov AV
    Haematologica; 2017 Nov; 102(11):1890-1900. PubMed ID: 28838991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.
    Polk A; Lu Y; Wang T; Seymour E; Bailey NG; Singer JW; Boonstra PS; Lim MS; Malek S; Wilcox RA
    Clin Cancer Res; 2016 Dec; 22(24):6118-6128. PubMed ID: 27334834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia.
    Zhang W; Kater AP; Widhopf GF; Chuang HY; Enzler T; James DF; Poustovoitov M; Tseng PH; Janz S; Hoh C; Herschman H; Karin M; Kipps TJ
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18956-60. PubMed ID: 20956327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia.
    Sanchez-Lopez E; Ghia EM; Antonucci L; Sharma N; Rassenti LZ; Xu J; Sun B; Kipps TJ; Karin M
    Cell Death Differ; 2020 Jul; 27(7):2206-2216. PubMed ID: 31992855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
    Longo PG; Laurenti L; Gobessi S; Sica S; Leone G; Efremov DG
    Blood; 2008 Jan; 111(2):846-55. PubMed ID: 17928528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia.
    Capitani N; Lucherini OM; Sozzi E; Ferro M; Giommoni N; Finetti F; De Falco G; Cencini E; Raspadori D; Pelicci PG; Lauria F; Forconi F; Baldari CT
    Blood; 2010 May; 115(18):3726-36. PubMed ID: 20061561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.
    Nishio M; Endo T; Tsukada N; Ohata J; Kitada S; Reed JC; Zvaifler NJ; Kipps TJ
    Blood; 2005 Aug; 106(3):1012-20. PubMed ID: 15860672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation.
    Azoulay D; Herishanu Y; Shapiro M; Brandshaft Y; Suriu C; Akria L; Braester A
    Exp Hematol; 2018 Jul; 63():17-21.e1. PubMed ID: 29705266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the NTSR2/TrkB oncogenic pathway in chronic lymphocytic leukemia.
    Ikhlef L; Yassine M; Chandouri B; Rivière L; Naves T; Dmytruk N; Gachard N; Jauberteau MO; Gallet PF
    Sci Rep; 2024 Mar; 14(1):6084. PubMed ID: 38480783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocyte truncated tropomyosin receptor kinase B mediates brain-derived neurotrophic factor anti-apoptotic effect leading to neuroprotection.
    Saba J; Turati J; Ramírez D; Carniglia L; Durand D; Lasaga M; Caruso C
    J Neurochem; 2018 Sep; 146(6):686-702. PubMed ID: 29851427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells.
    Nimmanapalli R; Lyu MA; Du M; Keating MJ; Rosenblum MG; Gandhi V
    Blood; 2007 Mar; 109(6):2557-64. PubMed ID: 17119117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
    Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
    Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain.
    Redondo-Muñoz J; Ugarte-Berzal E; Terol MJ; Van den Steen PE; Hernández del Cerro M; Roderfeld M; Roeb E; Opdenakker G; García-Marco JA; García-Pardo A
    Cancer Cell; 2010 Feb; 17(2):160-72. PubMed ID: 20159608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
    van Attekum MHA; Terpstra S; Slinger E; von Lindern M; Moerland PD; Jongejan A; Kater AP; Eldering E
    Oncogene; 2017 Jun; 36(26):3651-3660. PubMed ID: 28192408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1.
    Herishanu Y; Gibellini F; Njuguna N; Hazan-Halevy I; Farooqui M; Bern S; Keyvanfar K; Lee E; Wilson W; Wiestner A
    Leuk Lymphoma; 2011 Sep; 52(9):1758-69. PubMed ID: 21649540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells.
    Poggi A; Prevosto C; Catellani S; Rocco I; Garuti A; Zocchi MR
    Br J Haematol; 2010 Nov; 151(3):252-64. PubMed ID: 20813004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.